Medical Imaging Corporation (TPEX:6637)
74.00
-1.70 (-2.25%)
At close: Feb 11, 2026
Medical Imaging Market Cap
Medical Imaging has a market cap or net worth of 1.98 billion as of February 13, 2026. Its market cap has decreased by -6.84% in one year.
Market Cap
1.98B
Enterprise Value
1.91B
Revenue
1.12B
Ranking
n/a
PE Ratio
9.86
Stock Price
74.00
Market Cap Chart
Since June 26, 2017, Medical Imaging's market cap has increased from 1.01B to 1.98B, an increase of 96.98%. That is a compound annual growth rate of 8.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.98B | -4.76% |
| Dec 31, 2025 | 2.08B | -9.23% |
| Dec 31, 2024 | 2.29B | 28.90% |
| Dec 29, 2023 | 1.78B | 70.43% |
| Dec 30, 2022 | 1.04B | 18.20% |
| Dec 30, 2021 | 883.74M | -26.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| TSH Biopharm Corporation | 2.15B |
| Chunghwa Chemical Synthesis & Biotech | 2.07B |
| OK Biotech | 2.00B |
| DIVA Laboratories | 1.97B |